Success Metrics

Clinical Success Rate
89.3%

Based on 25 completed trials

Completion Rate
89%(25/28)
Active Trials
0(0%)
Results Posted
40%(10 trials)
Terminated
3(9%)

Phase Distribution

Ph phase_2
5
15%
Ph phase_3
11
33%
Ph phase_4
14
42%
Ph not_applicable
1
3%

Phase Distribution

0

Early Stage

5

Mid Stage

25

Late Stage

Phase Distribution31 total trials
Phase 2Efficacy & side effects
5(16.1%)
Phase 3Large-scale testing
11(35.5%)
Phase 4Post-market surveillance
14(45.2%)
N/ANon-phased studies
1(3.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

25 of 30 finished

Non-Completion Rate

16.7%

5 ended early

Currently Active

0

trials recruiting

Total Trials

33

all time

Status Distribution
Completed(25)
Terminated(5)
Other(3)

Detailed Status

Completed25
unknown3
Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
33
Active
0
Success Rate
89.3%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (16.1%)
Phase 311 (35.5%)
Phase 414 (45.2%)
N/A1 (3.2%)

Trials by Status

completed2576%
unknown39%
terminated39%
withdrawn26%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT04321837Phase 2

Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate

Completed
NCT06022237Not Applicable

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Unknown
NCT01077817

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Completed
NCT00092053Phase 3

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Completed
NCT03186131Phase 2

Efficacy of Oral Ibandronate in Osteoporosis

Unknown
NCT00662077Phase 4

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

Withdrawn
NCT00824993Phase 3

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Completed
NCT00666627Phase 2

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Completed
NCT00327990Phase 4

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

Completed
NCT02114489Phase 3

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis

Terminated
NCT00148915Phase 4

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

Completed
NCT02564107Phase 4

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Completed
NCT02561039Phase 3

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Completed
NCT02598453Phase 4

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

Completed
NCT02598440Phase 4

A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Completed
NCT02604836Phase 4

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Completed
NCT02948881Phase 4

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

Completed
NCT00545779Phase 3

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Completed
NCT00545363Phase 4

A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Completed
NCT02739594Phase 3

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
33